Filter posts

#BIOCEO18: Paradigm Shift Creating New Opportunities in China

The past few years have been a time of tremendous change in the world’s second …

#BIOCEO18: “A Moment Decades in the Making”

It’s a first-of-its-kind gene therapy ever approved by the U.S. Food and Drug Administration, marking …

BIO Releases Report on Investment in Pain and Addiction Therapeutics

BIO’s Industry Analysis team has released its second report in a new series on the …

Here We Go Again (But In a Good Way)

“We achieved the lowest drug trend since we began measuring drug trend data in 1993.” …

High Caliber Investors Flock to BIO CEO & Investor Conference

Today the 20th BIO CEO & Investor Conference opens in New York City amid a …

Flashback Friday: BIO CEO & Senior Managers Conference 1995

This post is part of BIO’s yearlong, bi-weekly series called Flashback Friday, highlighting newsletter stories …